semaglutide cardiovascular news #VisualAbstract: and Outcomes in Obesity without Diabetes Semaglutide and Cardiovascular Outcomes in

The manuscript bears communication number IU/R&D/2025-MCN0003818 from the Integral University, Lucknow

As semaglutide often leads to lower calorie intake, muscle mass can decline without physical resistance

We combine advanced technology, the latest treatments, and a comfortable, welcoming environment to give you results that feel just right

Vomiting was reported by 24% of the patients, diarrhea by 30%, constipation 24%, abdominal pain 20%, headache 14%, fatigue (tiredness) 11%, indigestion 9%, dizziness 8%, abdominal bloating 7%, flatulence 6%, loud burping 7%, low blood sugar (hypoglycemia) 6% and other side effects